Yungjin Pharm. Co., Ltd. (003520.KS)
KRW 1989.0
(-2.02%)
KRW 1989.0
(-2.02%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 234.9 Billion | 218.38 Billion | 196.06 Billion | 208.46 Billion | 220.51 Billion | 186.4 Billion |
| Cost of Revenue | 163.96 Billion | 153.64 Billion | 138.13 Billion | 135 Billion | 140.74 Billion | 124.96 Billion |
| Gross Profit | 70.93 Billion | 64.73 Billion | 57.93 Billion | 73.46 Billion | 79.77 Billion | 61.44 Billion |
| Operating Expenses | 69.46 Billion | 72.09 Billion | 71.81 Billion | 73.08 Billion | 69.79 Billion | 63.62 Billion |
| Selling, General and Administrative Expenses | 24.04 Billion | 22.43 Billion | 23.8 Billion | 24.64 Billion | 24.91 Billion | 21.5 Billion |
| Research and Development Expenses | 11.9 Billion | 14.36 Billion | 13.26 Billion | 15.07 Billion | 13.51 Billion | 11.98 Billion |
| Other Expenses | 33.04 Billion | 35.3 Billion | 34.74 Billion | 33.36 Billion | 31.36 Billion | 250.29 Million |
| Cost and Expenses | 231.78 Billion | 225.74 Billion | 209.94 Billion | 208.08 Billion | 210.53 Billion | 188.59 Billion |
| Operating Income | 3.11 Billion | -7.36 Billion | -13.87 Billion | 694.51 Million | 9.98 Billion | -2.18 Billion |
| Interest Expense | 2.87 Billion | 736.56 Million | 208.96 Million | 253.24 Million | 427.37 Million | 272.62 Million |
| Income Tax Expense | -42.35 Million | -851.73 Million | -2.56 Billion | 374.38 Million | 4.37 Billion | -550.6 Million |
| Earnings before Tax | -3.91 Billion | -22.81 Billion | -14.14 Billion | 241.26 Million | 9.4 Billion | -6.65 Billion |
| Net Income | -3.87 Billion | -21.96 Billion | -11.58 Billion | -133.12 Million | 5.02 Billion | -6.1 Billion |
| Earnings Per Share Basic | -21.00 | -120.08 | -63.33 | -0.73 | 27.50 | -33.36 |
| Earnings Per Share Diluted | -21.19 | -120.08 | -63.33 | -0.73 | 27.50 | -33.00 |
| Weighted Average Shares Outstanding | 184.54 Million | 182.89 Million | 182.89 Million | 182.89 Million | 182.89 Million | 182.89 Million |
| Weighted Average Shares Outstanding (Diluted) | 182.89 Million | 182.89 Million | 182.89 Million | 182.89 Million | 182.89 Million | 184.87 Million |
| Gross Margin | 0.30 | 0.30 | 0.30 | 0.35 | 0.36 | 0.33 |
| EBIT Margin | 0.03 | -0.06 | -0.03 | 0.04 | 0.08 | 0.03 |
| Profit Margin | -0.02 | -0.10 | -0.06 | -0.00 | 0.02 | -0.03 |
| EBITDA | 7.64 Billion | -14.29 Billion | -6.55 Billion | 8.27 Billion | 17.3 Billion | 4.45 Billion |
| Earnings Before Tax Margin | 0.01 | -0.03 | -0.07 | 0.00 | 0.05 | -0.01 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 62.04 Billion | 62.2 Billion | 64.94 Billion | 234.9 Billion | 64.31 Billion | 59.36 Billion |
| Cost of Revenue | - | 42.7 Billion | 44.13 Billion | 163.96 Billion | 44.44 Billion | 41.26 Billion |
| Gross Profit | 62.04 Billion | 19.5 Billion | 20.81 Billion | 70.93 Billion | 19.86 Billion | 18.1 Billion |
| Operating Expenses | 60.72 Billion | 18.29 Billion | 16.21 Billion | 67.82 Billion | 17.27 Billion | -17.78 Billion |
| Selling, General and Administrative Expenses | - | 14.9 Billion | 13.36 Billion | - | 15.95 Billion | 17.78 Billion |
| Research and Development Expenses | - | 3.29 Billion | 2.74 Billion | - | 1.23 Billion | 3.44 Billion |
| Other Expenses | -60.72 Billion | -86.37 Million | -100.58 Million | -402.64 Million | -88.31 Million | -35.57 Billion |
| Cost and Expenses | 60.72 Billion | 60.99 Billion | 60.34 Billion | 231.78 Billion | 61.71 Billion | 41.26 Billion |
| Operating Income | 1.32 Billion | 1.2 Billion | 4.6 Billion | 3.11 Billion | 2.59 Billion | 320.11 Million |
| Interest Expense | - | - | 1.43 Billion | 2.95 Billion | 1.06 Billion | 609.61 Million |
| Income Tax Expense | 128 Million | 163.55 Million | 1.05 Billion | -42.35 Million | -54.23 Million | 89.79 Million |
| Earnings before Tax | -309 Million | -1.29 Billion | 5.14 Billion | -3.91 Billion | -1.21 Billion | -785.78 Million |
| Net Income | -437 Million | -1.45 Billion | 4.09 Billion | -3.87 Billion | -1.16 Billion | -875.57 Million |
| Earnings Per Share Basic | -2.39 | -7.96 | 22.38 | - | -6.37 | -4.79 |
| Earnings Per Share Diluted | -2.39 | -7.96 | 22.38 | - | -6.37 | -4.79 |
| Weighted Average Shares Outstanding | 182.89 Million | 182.89 Million | 182.89 Million | 182.89 Million | 182.89 Million | 182.89 Million |
| Weighted Average Shares Outstanding (Diluted) | 182.89 Million | 182.89 Million | 182.89 Million | 182.89 Million | 182.89 Million | 182.89 Million |
| Gross Margin | 1.00 | 0.31 | 0.32 | 0.30 | 0.31 | 0.30 |
| EBIT Margin | 0.02 | 0.05 | 0.10 | - | 0.07 | 0.30 |
| Profit Margin | -0.01 | -0.02 | 0.06 | -0.02 | -0.02 | -0.01 |
| EBITDA | 1.32 Billion | 3.37 Billion | 6.78 Billion | - | 4.73 Billion | 18.1 Billion |
| Earnings Before Tax Margin | 0.02 | 0.02 | 0.07 | 0.01 | 0.04 | 0.01 |
2441
BHAC
TRVI
THYAO
6115
ACLIF